NextCure Inc expected to post a loss of 59  cents a share - Earnings Preview

NextCure

03/05/2021 13:01

* NextCure Inc  NXTC.OQ   NXTC.O  is expected to show a fall in
quarterly revenue when it reports results on May 5 (estimated).
* The Beltsville, Maryland-based company is expected to report
 a 100.0% decrease in revenue to $0 from $22.38 million a year
ago, according to the mean estimate from 6 analysts, based on
Refinitiv data.​​
​* Refinitiv's mean analyst estimate for NextCure Inc is for a
loss of 59 cents per share. For the same quarter last year, the
company reported earnings of 33 cents per share.
* The current average analyst rating on the shares is "buy" and
the breakdown of recommendations is 5 "strong buy" or "buy," 3
"hold" and 1 "sell" or "strong sell." 
* The mean earnings estimate of analysts was unchanged in the
last three months.​
* Wall Street's median 12-month price target for NextCure Inc is
$18​, about 51.3% above​ its last closing price of $8.77. ​​​
* Previous quarterly performance (using preferred earnings
measure in US dollars). ​
 QUARTER       STARMINE    REFINITIV  ACTUAL    BEAT,   SURPRI
 ENDING        SMARTESTIM  IBES                 MET,    SE %
               ATE®        ESTIMATE             MISSED  
 Dec. 31 2020  -0.61       -0.60      -0.54     Beat    9.7
 Sep. 30 2020  -0.56       -0.57      -0.59     Missed  -4.2
 Jun. 30 2020  -0.51       -0.50      -0.53     Missed  -5.8​
 Mar. 31 2020  -0.44       -0.44      0.33      Beat    174.5
 Dec.          -0.46​      -0.45      -0.34     Beat    25.4​
 31​ 2019​                                              
 Sep. 30 2019  -0.35       -0.35      -0.37     Missed  -5.7​
 Jun. 30 2019  -0.48       -0.46      -0.61     Missed  -31.2
 Mar. 31 2019  -0.53       -0.53      -4.46     Missed  -741.5
 This summary was machine generated May 3 at 12:01 GMT.  All
figures in US dollars unless otherwise stated